Redox Active Molecules in Cancer Treatments
The book is a reprint of a Special Issue with the same title published online in the chemical journal Molecules (ISSN 1420-3049) within the section of Medicinal Chemistry. It was edited by academic guest editors from September 2020 to April 2022. In total, it includes eighteen research/review articl...
Format: | eBook |
---|---|
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2023
|
Subjects: | |
Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
LEADER | 04887namaa2201549uu 4500 | ||
---|---|---|---|
001 | doab98096 | ||
003 | oapen | ||
005 | 20230307 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 230307s2023 xx |||||o ||| 0|eng d | ||
020 | |a 9783036567303 | ||
020 | |a 9783036567310 | ||
020 | |a books978-3-0365-6730-3 | ||
024 | 7 | |a 10.3390/books978-3-0365-6730-3 |2 doi | |
040 | |a oapen |c oapen | ||
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a TB |2 bicssc | |
072 | 7 | |a TBX |2 bicssc | |
720 | 1 | |a Stepanić, Višnja |4 edt | |
720 | 1 | |a Kučerová-Chlupáčová, Marta |4 edt | |
720 | 1 | |a Kučerová-Chlupáčová, Marta |4 oth | |
720 | 1 | |a Stepanić, Višnja |4 oth | |
245 | 0 | 0 | |a Redox Active Molecules in Cancer Treatments |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2023 | ||
300 | |a 1 online resource (298 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
520 | |a The book is a reprint of a Special Issue with the same title published online in the chemical journal Molecules (ISSN 1420-3049) within the section of Medicinal Chemistry. It was edited by academic guest editors from September 2020 to April 2022. In total, it includes eighteen research/review articles including the editorial. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a History of engineering and technology |2 bicssc | |
650 | 7 | |a Technology: general issues |2 bicssc | |
653 | |a acute myeloid leukemia (AML) | ||
653 | |a Anneslea fragrans | ||
653 | |a anticancer | ||
653 | |a antioxidant | ||
653 | |a antioxidant capacity | ||
653 | |a apoptosis | ||
653 | |a AQP3 | ||
653 | |a AQP5 | ||
653 | |a astaxanthin | ||
653 | |a autophagy | ||
653 | |a bioenergetics | ||
653 | |a breast cancer | ||
653 | |a cancer | ||
653 | |a cancer cells | ||
653 | |a Casiopeina | ||
653 | |a cell cycle | ||
653 | |a cell cycle arrest | ||
653 | |a chain-transfer agent | ||
653 | |a cheminformatics | ||
653 | |a chemotherapy | ||
653 | |a cluster analysis | ||
653 | |a colorectal cancer cells | ||
653 | |a conjugation | ||
653 | |a copper complexes | ||
653 | |a copper reduction | ||
653 | |a cysteine | ||
653 | |a dendrogram analysis | ||
653 | |a dihydroxyphenyl-γ-valerolactone | ||
653 | |a drug-likeness | ||
653 | |a endoplasmic reticulum stress | ||
653 | |a ER stress | ||
653 | |a ferroptosis | ||
653 | |a flavonoid glycosides | ||
653 | |a free radical chain reaction | ||
653 | |a glutathione depletion | ||
653 | |a guided isolation | ||
653 | |a HepG2 | ||
653 | |a HHDP-digalloylglucose isomer | ||
653 | |a hierarchical clustering | ||
653 | |a HT29 cells | ||
653 | |a hydrogen peroxide | ||
653 | |a hydrolysable tannins | ||
653 | |a in silico | ||
653 | |a inducers | ||
653 | |a inhibitors | ||
653 | |a intermediate | ||
653 | |a ionizing radiations | ||
653 | |a Keap1 | ||
653 | |a lipid peroxidation | ||
653 | |a lipophilic thiol | ||
653 | |a luminescence lifetime | ||
653 | |a macrophages | ||
653 | |a magnetite nanoparticles | ||
653 | |a MCL-1 inhibitor S63845 | ||
653 | |a melatonin | ||
653 | |a metformin | ||
653 | |a mitochondria | ||
653 | |a molecular docking | ||
653 | |a molecular dynamics | ||
653 | |a morphology | ||
653 | |a multicomponent reaction | ||
653 | |a myeloperoxidase | ||
653 | |a n/a | ||
653 | |a NADPH oxidase | ||
653 | |a naringenin | ||
653 | |a neurodegenerative | ||
653 | |a NRF2 | ||
653 | |a osteosarcoma | ||
653 | |a oxidative cell death | ||
653 | |a oxidative stress | ||
653 | |a oxygen detection | ||
653 | |a papaverine | ||
653 | |a particle encapsulation | ||
653 | |a pentoxifylline | ||
653 | |a peptides | ||
653 | |a photodynamic therapy | ||
653 | |a polyphenol | ||
653 | |a polyphenols | ||
653 | |a principal component analysis | ||
653 | |a proliferation | ||
653 | |a prooxidative drug | ||
653 | |a radiation-induced fibrosis | ||
653 | |a radical propagation | ||
653 | |a rate-limiting step | ||
653 | |a reactive oxygen species | ||
653 | |a reactive oxygen species (ROS) | ||
653 | |a Rhopilema nomadica | ||
653 | |a ROS | ||
653 | |a seed antioxidant peptide | ||
653 | |a soybean | ||
653 | |a spheroids | ||
653 | |a time-resolved imaging | ||
653 | |a xanthine oxidase | ||
793 | 0 | |a DOAB Library. | |
856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/98096 |7 0 |z Open Access: DOAB: description of the publication |
856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/6868 |7 0 |z Open Access: DOAB, download the publication |